Sign up to save your podcasts
Or
Share Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
130 Listeners
Global News Podcast
7,678 Listeners
Neurology® Podcast
284 Listeners
NEJM This Week
319 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
494 Listeners
JAMA Neurology Author Interviews
14 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
363 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
77 Listeners